VISION EUROPE 2030: Disruptive Technologies, Democratized Trials & Next-Gen Treatment Paradigms

The European Alliance for Personalised Medicine (EAPM) will host the upcoming VISION Europe 2030 conference, taking place from 2–3 September 2025 at the Club University Foundation in Brussels. This high-level event, co-funded by the EU4Health programme, brings together policymakers, clinicians, researchers, patients, and industry leaders to drive forward a common agenda: aligning disruptive technologies with scalable, equitable, and system-wide reform across healthcare.

Under the theme “Disruptive Technologies, Democratized Trials & Next-Gen Treatment Paradigms,” the conference addresses one of the most urgent challenges of our time—how to bridge the widening gap between what science makes possible and what health systems deliver in practice.

EBRAINS Joint-CEO Philippe Vernier will participate in the panel 'Spotlight 2: Bridging the Innovation Gap: Precision Neurology for the Next Decade' on 2 September from 16:30-17:30. The panel will also feature:

• Frédéric Destrebecq, Executive Director, European Brain Council 

• Philippe Amouyel, French Foundation of Scientific co-operation in Alzheimer’s Disease, France 

• Roberto Grasso, Department of Oncology and Hemato-Oncology, University of Milan 

• Rossana Alessandrello, Value Based Procurement Director, AQUAS 

Click here to find out more about the event.